Related Articles
Expression of UCP2 is associated with sensitivity to platinum‑based chemotherapy for ovarian serous carcinoma
TBX2 expression is associated with platinum‑sensitivity of ovarian serous carcinoma
Neutrophil‑to‑lymphocyte ratio is associated with sensitivity to platinum‑based chemotherapy and prognosis in patients with advanced serous ovarian carcinoma
PRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Role of Fyn expression in predicting the sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma